Vijaya Bhatt, MD
Hematology & Oncology · Omaha, NENPI 1760612113
Payments from drug & device makers
Across 210 payments — averaging $10,257 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$1.2M
- Jazz Pharmaceuticals Inc.$609K
- Sanofi US Services Inc.$186K
- Astellas Pharma Global Development$64K
- Pfizer$59K
- AbbVie$11K
- plus $44K from 13 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 105 | $1,182,372 |
| Jazz Pharmaceuticals Inc. | 28 | $608,584 |
| Sanofi US Services Inc. | 6 | $185,673 |
| Astellas Pharma Global Development | 6 | $63,628 |
| Pfizer | 3 | $59,000 |
| AbbVie | 20 | $10,722 |
| Syndax Pharmaceuticals, Inc. | 5 | $8,067 |
| Agios Pharmaceuticals, Inc. | 8 | $5,968 |
| Genentech USA, Inc. | 3 | $4,950 |
| National Marrow Donor Program | 1 | $4,708 |
| Sanofi-aventis U.S. LLC | 5 | $4,375 |
| Servier Pharmaceuticals LLC | 2 | $4,280 |
| Geron Corporation | 3 | $3,016 |
| Omeros Corporation | 4 | $2,894 |
| Taiho Oncology, Inc. | 4 | $2,518 |
| Bristol Myers Squibb | 4 | $1,615 |
| Rigel Pharmaceuticals, Inc. | 1 | $1,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $660 |
| Novartis | 1 | $1 |
How this compares
$2,154,031 in reported general payments places this provider in the 85th percentile of 73 hematology & oncology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Omaha
- Luke NordquistOmaha$29.3M
- Ralph HaukeOmaha$12.1M
- Margaret BlockOmaha$8.3M
- Stefano TarantoloOmaha$3.7M
- Julie VoseOmaha$3.5M
- Robert BociekOmaha$3M
- Mojtaba AkhtariOmaha$1.9M
- Mary WellsOmaha$1.6M
- Robert LangdonOmaha$1.2M
- Yungpo SuOmaha$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.